BlackRock
STIM icon

BlackRock’s Neuronetics STIM Stock Holding History

BlackRock’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$776K Sell
596,622
-1,721,915
-74% -$2.51M ﹤0.01% 4438
2026
Q1 		$3.36M Sell
2,318,537
-35,214
-1% -$55.8K ﹤0.01% 3978
2025
Q4 		$3.25M Buy
2,353,751
+50,250
+2% +$105K ﹤0.01% 3984
2025
Q3 		$6.29M Buy
2,303,501
+64,277
+3% +$228K ﹤0.01% 3674
2025
Q2 		$7.81M Buy
2,239,224
+1,823,354
+438% +$7.2M ﹤0.01% 3549
2025
Q1 		$1.53M Buy
415,870
+31,180
+8% +$114K ﹤0.01% 4070
2024
Q4 		$619K Buy
384,690
+428
+0.1% +$445 ﹤0.01% 4356
2024
Q3 		$292K Buy
384,262
+2,568
+0.7% +$3.37K ﹤0.01% 4449
2024
Q2 		$687K Buy
381,694
+1,150
+0.3% +$3.32K ﹤0.01% 4270
2024
Q1 		$1.81M Buy
380,544
+415
+0.1% +$1.46K ﹤0.01% 4031
2023
Q4 		$1.1M Sell
380,129
-786
-0.2% -$1.24K ﹤0.01% 4225
2023
Q3 		$514K Sell
380,915
-2,820
-0.7% -$4.94K ﹤0.01% 4417
2023
Q2 		$825K Buy
383,735
+5,117
+1% +$12.4K ﹤0.01% 4336
2023
Q1 		$1.1M Sell
378,618
-40,649
-10% -$205K ﹤0.01% 4306
2022
Q4 		$2.88M Buy
419,267
+2,960
+0.7% +$14K ﹤0.01% 3973
2022
Q3 		$1.32M Sell
416,307
-4,259
-1% -$15.5K ﹤0.01% 4380
2022
Q2 		$1.35M Sell
420,566
-1,155,216
-73% -$3.35M ﹤0.01% 4410
2022
Q1 		$4.77M Sell
1,575,782
-18,691
-1% -$63.2K ﹤0.01% 3991
2021
Q4 		$7.11M Buy
1,594,473
+22,773
+1% +$112K ﹤0.01% 3848
2021
Q3 		$10.3M Buy
1,571,700
+45,723
+3% +$439K ﹤0.01% 3658
2021
Q2 		$24.4M Buy
1,525,977
+1,098,612
+257% +$15.2M ﹤0.01% 3176
2021
Q1 		$5.29M Buy
427,365
+162,141
+61% +$2.49M ﹤0.01% 3921
2020
Q4 		$2.95M Sell
265,224
-24,238
-8% -$182K ﹤0.01% 3904
2020
Q3 		$1.41M Buy
289,462
+18,511
+7% +$70.2K ﹤0.01% 4004
2020
Q2 		$523K Sell
270,951
-629,790
-70% -$1.29M ﹤0.01% 4199
2020
Q1 		$1.7M Buy
900,741
+24,937
+3% +$78K ﹤0.01% 3703
2019
Q4 		$3.93M Sell
875,804
-138,033
-14% -$858K ﹤0.01% 3571
2019
Q3 		$8.43M Buy
1,013,837
+35,793
+4% +$391K ﹤0.01% 3292
2019
Q2 		$12.2M Buy
978,044
+57,297
+6% +$810K ﹤0.01% 3135
2019
Q1 		$14M Buy
920,747
+308,324
+50% +$5.1M ﹤0.01% 2932
2018
Q4 		$11.9M Buy
612,423
+203,983
+50% +$4.48M ﹤0.01% 2996
2018
Q3 		$13.1M Buy
408,440
+405,940
+16,238% +$12.3M ﹤0.01% 3099
2018
Q2 		$66K Buy
+2,500
New +$68K ﹤0.01% 4525

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BlackRock's STIM Position: Q2 2026 in Review

BlackRock reduced its Neuronetics (STIM) stake by 74% in Q2 2026, selling an estimated $2.51M and leaving 596,622 shares worth $776K. The position accounts for ﹤0.01% of the portfolio, ranked #4438.

BlackRock first reported a position in STIM in Q2 2018 and has held it in 33 quarters since. The position peaked at $24.4M in Q2 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • BlackRock held 596,622 shares of Neuronetics worth $776K as of Q2 2026.
  • BlackRock sold 1,721,915 Neuronetics shares in Q2 2026, an estimated $2.51M.
  • Neuronetics made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4438 holding.
  • BlackRock first reported a position in Neuronetics in Q2 2018 and has held it in 33 quarters since.
  • BlackRock's Neuronetics position peaked at $24.4M in Q2 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.